Indegene Enterprise Value (EV)

Indegene Ltd Enterprise Value

The Indegene Ltd Enterprise Value is a key financial metric used by investors to evaluate Indegene Ltd's valuation, profitability, and overall financial performance. Tracking the Indegene Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Indegene Ltd (NSE: INDGN, BSE: 544172) is currently trading at ₹474.70, with a market capitalization of ₹113.03B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Indegene Ltd Enterprise Value is essential for fundamental analysis.

Indegene Ltd Enterprise Value Current Value

The current Indegene Ltd Enterprise Value stands at 122.53B.

The latest Indegene Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Indegene Ltd Enterprise Value Historical Trend

The Indegene Ltd Enterprise Value has shown the following historical trend:

• 2024: 122.53B
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The recent rise in Indegene Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What Indegene Ltd Enterprise Value Indicates for Investors

The Indegene Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Indegene Ltd.

Indegene Ltd Enterprise Value Analysis Summary

The Indegene Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indegene Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Indegene Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.